Publications
Detailed Information
Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
Cited 39 time in
Web of Science
Cited 39 time in Scopus
- Authors
- Issue Date
- 2017-10-17
- Publisher
- BioMed Central
- Citation
- Alzheimer's Research & Therapy, 9(1):86
- Keywords
- Multimer detection system ; Alzheimer’s disease ; Amyloid-β ; Oligomers ; Blood biomarker ; Synthetic amyloid-β ; ELISA ; Plasma test
- Abstract
- Abstract
Background
A reliable blood-based assay is required to properly diagnose and monitor Alzheimers disease (AD). Many attempts have been made to develop such a diagnostic tool by measuring amyloid-β oligomers (AβOs) in the blood, but none have been successful in terms of method reliability. We present a multimer detection system (MDS), initially developed for the detection of prion oligomers in the blood, to detect AβOs.
Methods
To characterize Aβ in the blood, plasma was spiked with synthetic amyloid-β (Aβ) and incubated over time. Then, the MDS was used to monitor the dynamic changes of AβO levels in the plasma.
Results
Increasing concentrations of AβOs were observed in the plasma of patients with AD but not in the plasma of normal control subjects. The plasma from patients with AD (n = 27) was differentiated from that of the age-matched normal control subjects (n = 144) with a sensitivity of 83.3% and a specificity of 90.0%.
Conclusions
Synthetic Aβ spiked into the blood plasma of patients with AD, but that of not elderly normal control subjects, induced dynamic changes in the formation of AβOs over time. AβOs were detected by the MDS, which is a useful blood-based assay with high sensitivity and specificity for AD diagnosis.
- ISSN
- 1758-9193
- Language
- English
- Files in This Item:
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.